Madrigal Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $362.6M
Liabilities Breakdown FY2022
Total Liabilities: $165.2M
Asset Breakdown
Total Assets: $362.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $331.5M | 91.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $601.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $30.4M | 8.4% |
Liabilities Breakdown
Total Liabilities: $165.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $23.8M | 14.4% |
| Long-Term Debt | $49.3M | 29.8% |
| Other Liabilities | $92.1M | 55.7% |